| Alyssa Tallon, LAC | |
|
5 Opal Pl, Aberdeen, NJ 07747-2105 | |
| (732) 546-6663 | |
| Not Available |
| Full Name | Alyssa Tallon |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 5 Opal Pl, Aberdeen, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477110450 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 37AC00417800 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Tallon, LAC 219 Taylors Millds Rd, Englishtown, NJ 07726 Ph: (908) 415-2042 | Alyssa Tallon, LAC 5 Opal Pl, Aberdeen, NJ 07747-2105 Ph: (732) 546-6663 |
News Archive
The report, published in the prestigious international journal, the British Journal of Obstetrics and Gynaecology, found that the rise could not be explained by increases in clinical reasons for caesareans such as complications in pregnancy or labour/delivery and was more likely due to societal factors.
Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease.
Sunstone Capital has signed an investment agreement with IMIX, an end-user provider of superior digital radiography (DR) systems for hospitals and specialist clinics. Simultaneously IMIX and ARCOMA AB, a leading OEM supplier of medical and radiology systems and sub-systems, have signed a Letter of Intent to combine the activities of the two companies in a single holding company, IMIX Holding AB. The combined company will become a leading global supplier of radiographic solutions.
In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.
› Verified 3 days ago
Ms. Kristen R. Materek, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Chris Desilvestri, LMFT LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 506 Laurie Ln, Aberdeen, NJ 07747 Phone: 732-309-6104 | |
Patricia Smith, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Ms. Pennie L. Colleton, NCC, LPC, LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6 Second Street, Aberdeen, NJ 07747 Phone: 732-744-4406 | |
Alison M D'auguste, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Donna Coyle, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 |